Prevalence and factors contributing to urogenital tuberculosis among HIV patients attaining healthcare at Hoima Regional Referral Hospital. A cross-sectional study.
DOI:
https://doi.org/10.51168/nhcry685Keywords:
: Tuberculosis, Urogenital tuberculosis, TB screening, Extrapulmonary tuberculosis, GeneXpertAbstract
Background:
The study aimed to determine the prevalence and factors contributing to urogenital tuberculosis among HIV-positive patients attending healthcare at Hoima Regional Referral Hospital.
Methodology:
A hospital-based retrospective cross-sectional study design utilizing secondary data was employed. Data were collected from patient medical records, ART clinic registers, and laboratory records of HIV-positive patients. A total of 112 patient records meeting the inclusion criteria were reviewed using a structured data extraction form. Data analysis was performed using SPSS version 26. Descriptive statistics including frequencies and percentages were used to summarize the findings, while Chi-square tests were used to determine associations between study variables and urogenital tuberculosis.
Results:
Among 112 HIV-positive patient records, 65 (58.0%) were female and 47 (42.0%) male. The largest age group was 36-45 years, 41 (36.6%), while 18-25 years accounted for 18 (16.1%). Semi-urban residents were 46 (41.1%), urban 32 (28.6%), and rural 34 (30.3%). Married participants were 51 (45.5%), single 39 (34.8%), divorced/separated 15 (13.4%), and widowed 7 (6.3%). Primary education accounted for 39 (34.8%), secondary 37 (33.0%), tertiary 20 (17.9%), and no formal education 16 (14.3%). Employed participants were 63 (56.3%) and unemployed 49 (43.7%). Urogenital tuberculosis was diagnosed in 14 (12.5%) records, while 98 (87.5%) were negative. Prevalence was 17.0% among males and 9.2% among females. By age, prevalence ranged from 5.6% to 16.7%. Rural residence was recorded at 14.7%, divorced at 20.0%, no formal education at 25.0%, and unemployment at 16.3%.
Conclusion:
Urogenital tuberculosis remains a significant public health concern among HIV-positive patients at Hoima Regional Referral Hospital, with socio-demographic factors influencing its occurrence.
Recommendation:
The study recommends strengthening routine TB screening, early diagnosis, access to diagnostic tests, health education, and integrated TB/HIV services among HIV-positive patients.
References
1. Broger, T., Nicol, M. P., Székely, R., et al. (2020). Diagnostic accuracy of a novel tuberculosis point-of-care urine lipoarabinomannan assay for people living with HIV: A meta-analysis of individual in- and outpatient data. PLoS Medicine, 17(5), e1003113. https://doi.org/10.1371/journal.pmed.1003113
2. Cresswell, F. V., Ellis, J., Kagimu, E., & et al. (2020). Standardized urine-based tuberculosis (TB) screening with TB-lipoarabinomannan and Xpert MTB/RIF Ultra in Ugandan adults with advanced human immunodeficiency virus disease and suspected meningitis. Open Forum Infectious Diseases, 7(4), ofaa100. https://doi.org/10.1093/ofid/ofaa100
3. Figueiredo, A. A., Lucon, A. M., & Srougi, M. (2017). Urogenital tuberculosis. Microbiology Spectrum, 5(1). https://doi.org/10.1128/microbiolspec.TNMI7-0015-2016
4. Hirpa, S., Tadesse, T., & Belachew, T. (2022). Gender differences in tuberculosis and HIV co-infection: A systematic review. International Journal of Infectious Diseases, 116, 154–162. https://doi.org/10.1016/j.ijid.2022.01.030
5. Mohammed, H., Assefa, N., & Mengistie, B. (2018). Prevalence of extrapulmonary tuberculosis among people living with HIV/AIDS in sub-Saharan Africa: A systematic review and meta-analysis. HIV/AIDS - Research and Palliative Care, 10, 225–237. https://doi.org/10.2147/HIV.S176587
6. Muneer, A., Macrae, B., Krishnamoorthy, S., & Zumla, A. (2019). Urogenital tuberculosis-epidemiology, pathogenesis and clinical features. Nature Reviews Urology, 16(10), 573–598. https://doi.org/10.1038/s41585-019-0228-9
7. Onwubiko, C., Ibekwe, P., & Nwankwo, E. (2024). Socio-demographic determinants of tuberculosis among HIV patients in Nigeria. BMC Public Health, 24(1), 88–96. https://doi.org/10.1186/s12889-024-17654-x
8. Shah, S., Kabange, L., & Mpunga, J. (2021). Urban–rural disparities in TB-HIV co-infection in the Democratic Republic of Congo. BMC Infectious Diseases, 21(1), 104. https://doi.org/10.1186/s12879-021-05801-1
9. World Health Organization. (2021). Global tuberculosis report 2021. https://iris.who.int/handle/10665/346387
10. World Health Organization. (2023). Global tuberculosis report 2023. https://iris.who.int/handle/10665/373828
11. World Health Organization. (2024). Global tuberculosis report 2024. https://iris.who.int/handle/10665/379339
12. Zhao, Y., Wang, L., & Zhang, H. (2025). Age and sex distribution of tuberculosis in HIV-positive populations. International Journal of Tuberculosis and Lung Disease, 29(2), 115–123.
